University of Colorado/Children's Hospital Colorado
Welcome,         Profile    Billing    Logout  
 6 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Arnold, Meghan A
NCT06185088: MENDD Tolerance Assessment Study

Terminated
N/A
1
US
Coda® Balloon Catheters, Double Balloon Endoscope (DBE)
University of Michigan
Short Bowel Syndrome
06/23
06/23
NCT04629014: Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

Recruiting
N/A
750
Canada, US
Boston Children's Hospital, Seattle Children's Hospital, University of Alabama at Birmingham, Ann & Robert H Lurie Children's Hospital of Chicago, Washington University School of Medicine, University of Michigan, Duke Health, University of Texas Southwestern Medical Center, Alberta Children's Hospital, British Columbia Children's Hospital, The Hospital for Sick Children
Pediatric Intestinal Failure
12/27
12/27
Yonker, Marcy
REBUILD-2, NCT04616326 / 2018-004622-28: A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

Recruiting
3
300
Europe, Japan, US, RoW
Galcanezumab, LY2951742, Placebo
Eli Lilly and Company
Chronic Migraine
07/25
03/26
REBUILD, NCT03432286 / 2017-004351-23: A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

Recruiting
3
325
Europe, Japan, US, RoW
Galcanezumab, LY2951742, Placebo
Eli Lilly and Company
Episodic Migraine
11/25
11/26
PIONEER-PEDS1, NCT04396236 / 2019-004378-24: A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting
3
1633
Europe, Japan, US, RoW
Lasmiditan, LY573144, Placebo
Eli Lilly and Company
Migraine
01/25
01/25
PIONEER-PEDS2, NCT04396574 / 2019-004379-38: A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting
3
1000
Europe, Japan, US, RoW
Lasmiditan, LY573144
Eli Lilly and Company
Migraine
03/26
03/26
NCT04715685: Mind Body Balance for Pediatric Migraine

Recruiting
N/A
260
US
40 minute session, 20 minute session, home practice e-health, home practice handout, phone call
Children's Hospital Medical Center, Cincinnati, National Center for Complementary and Integrative Health (NCCIH)
Headache, Headache Disorders, Headache, Migraine, Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura, Chronic Migraine
05/26
08/26
NCT05889624: Responding With Evidence and Access for Childhood Headaches

Recruiting
N/A
400
US
CBT, Cognitive Behavioral Therapy, Amitriptyline
Children's Hospital Medical Center, Cincinnati, Patient-Centered Outcomes Research Institute
Headache, Headache Disorders, Headache, Migraine, Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura, Chronic Migraine
07/27
12/27
Rastogi, Reena
NCT05889624: Responding With Evidence and Access for Childhood Headaches

Recruiting
N/A
400
US
CBT, Cognitive Behavioral Therapy, Amitriptyline
Children's Hospital Medical Center, Cincinnati, Patient-Centered Outcomes Research Institute
Headache, Headache Disorders, Headache, Migraine, Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura, Chronic Migraine
07/27
12/27
Lang, Lindsey
COMPASS, NCT05371613 / 2021-005200-35: A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) Vs Idursulfase in Pediatric and Young Adult Participants with Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)

Recruiting
2/3
54
Europe, Canada, US, RoW
tividenofusp alfa, idursulfase
Denali Therapeutics Inc.
Mucopolysaccharidosis II
12/25
12/25
NCT05889624: Responding With Evidence and Access for Childhood Headaches

Recruiting
N/A
400
US
CBT, Cognitive Behavioral Therapy, Amitriptyline
Children's Hospital Medical Center, Cincinnati, Patient-Centered Outcomes Research Institute
Headache, Headache Disorders, Headache, Migraine, Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura, Chronic Migraine
07/27
12/27

Download Options